A 62-year-old man with advanced pancreatic cancer presents with abdominal pain, bleeding from a gastric ulcer, and laboratory findings: PT 22 sec (control 12 sec), aPTT 48 sec (control 36 sec), fibrinogen 120 mg/dL (normal 200–400), platelet count 95,000/μL, and D-dimer 8 μg/mL (normal <0.5). What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis: Disseminated Intravascular Coagulation (DIC) ### Diagnostic Criteria Met | Finding | Patient Value | Normal Range | Significance | |---------|---------------|--------------|---------------| | PT | 22 sec | 12 sec | Prolonged | | aPTT | 48 sec | 36 sec | Prolonged | | Fibrinogen | 120 mg/dL | 200–400 mg/dL | **Low** | | Platelets | 95,000/μL | 150,000–400,000 | Thrombocytopenia | | D-dimer | 8 μg/mL | <0.5 μg/mL | **Markedly elevated** | | Clinical context | Pancreatic cancer + GI bleed | — | Tissue factor release | **Key Point:** This patient meets **ISTH DIC criteria** (≥5 points): - Prolonged PT (1 point) - Low fibrinogen (2 points) - Elevated D-dimer (3 points) - Thrombocytopenia (1 point) - **Total: ≥5 points = Overt DIC** ### Pathophysiology ```mermaid flowchart TD A[Pancreatic cancer<br/>+ GI ulcer bleed]:::outcome --> B[Massive tissue factor<br/>release]:::action B --> C[Activation of extrinsic<br/>coagulation cascade]:::action C --> D[Consumption of:<br/>Platelets, fibrinogen,<br/>factors V, VIII]:::outcome D --> E[Paradoxical bleeding<br/>+ thrombosis]:::urgent E --> F[Elevated D-dimer,<br/>PT, aPTT<br/>Low fibrinogen, platelets]:::outcome ``` ## Management of Overt DIC ### Immediate Steps 1. **Treat the underlying cause** — this is PARAMOUNT - Manage the bleeding ulcer (endoscopy, PPI, transfusion) - Oncologic management of pancreatic cancer - Without treating the trigger, replacement therapy alone fails 2. **Replace consumed factors and platelets** - **Fresh frozen plasma (FFP)**: replaces factors II, V, VII, X - **Cryoprecipitate**: replaces fibrinogen and factor VIII - **Platelet transfusion**: maintain platelets >50,000/μL (or >30,000 if no active bleeding) ### Why NOT Heparin? **Warning:** Heparin is **contraindicated** in DIC with active bleeding because: - It increases bleeding risk in the setting of consumption coagulopathy - It is only considered in **non-bleeding DIC** with thrombotic manifestations (rare) - This patient has active GI bleeding — heparin would worsen hemorrhage **High-Yield:** The mnemonic for DIC management is **"TREAT THE CAUSE + REPLACE WHAT'S LOST."** ### Why NOT Thrombolysis? - Thrombolysis is contraindicated in active bleeding and consumption coagulopathy - It would accelerate fibrinolysis and worsen hemorrhage - Thrombin time is not needed for diagnosis or management [cite:Harrison 21e Ch 140]